Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 7801 AL 7815

Targeting Alzheimer's disease pathology: influence of nano-based drug delivery systems loaded with a combination of herbal and synthetic drugs

Mumtaz, Unnithan D, Bano A, Chauhan APS, Ali J, Khan MA.

Expert Opin Drug Deliv. 2025 Aug;22(8):1155-1170. doi: 10.1080/17425247.2025.2513440. Epub 2025 Jun 18.

Large language models for Alzheimer's disease drug discovery

Alkam T, Tarshizi E, Van Benschoten AH.

J Alzheimers Dis. 2025 Aug;106(3):799-822. doi: 10.1177/13872877251346890. Epub 2025 Jun 2.

Thioredoxin-interacting protein: an emerging target for Alzheimer's disease

Patil R, Parab SB, Bhatt LK.

Eur J Pharmacol. 2025 Sep 5;1002:177806. doi: 10.1016/j.ejphar.2025.177806. Epub 2025 Jun 4.

Biomaterials in Alzheimer's Disease: An Anti-Neuroinflammatory Perspective

Huang N, Huang W, Wang M, Shi J, Luo Y, Huang J.

Adv Healthc Mater. 2025 Jul;14(19):e2500498. doi: 10.1002/adhm.202500498. Epub 2025 Jun 8.

Fighting Alzheimer's naturally: Peptides as multitarget drug leads

Spinelli R, Sanchís I, Siano A.

Bioorg Med Chem Lett. 2025 Nov 1;127:130305. doi: 10.1016/j.bmcl.2025.130305. Epub 2025 Jun 8.

Regulation of Blood-Brain Barrier Permeability via JNK Signaling Pathway: Mechanisms and Potential Therapeutic Strategies for Ischemic Stroke, Alzheimer's Disease and Brain Tumors

Plotnikov MB, Anishchenko AM, Khlebnikov AI, Schepetkin IA.

Molecules. 2025 May 28;30(11):2353. doi: 10.3390/molecules30112353.

Dual Aβ/tau epitope vaccines: a poorly explored strategy for Alzheimer's disease immunotherapy

León-Arcia K, Pérez-Leal G, Quintero-Álvarez H, Zamora-Loyarte DI, López-Armenteros M, de la Caridad Sánchez-Quesada A, Vázquez-Mojena Y.

Vaccine. 2025 Aug 13;61:127414. doi: 10.1016/j.vaccine.2025.127414. Epub 2025 Jun 21.

Sclerostin: A Potential Link between Osteoporosis and Alzheimer's Disease

Guo Z, Xu Q, Zhang K, Ma Y, Sheng S, Jing D, Sun X, Kan C, Yu X.

Neurodegener Dis. 2025;25(4):218-226. doi: 10.1159/000547072. Epub 2025 Jun 23.

Globalization of Alzheimer's disease clinical trials: Current characteristics and future goals

Cummings JL, Lindle J, Dalla I, Zhou Y, Zhong K, Cheng F.

Int Psychogeriatr. 2025 Dec;37(6):100108. doi: 10.1016/j.inpsyc.2025.100108. Epub 2025 Jun 23.

A Change of Mind: Targeting Amyloid-β with Better Safety Profile

Krick KE, Wilcock DM.

Annu Rev Pharmacol Toxicol. 2026 Jan;66(1):391-403. doi: 10.1146/annurev-pharmtox-062124-113434. Epub 2025 Jun 25.

Exploring prodrug approaches for Alzheimer's treatment: an overview

Kumari P, Kumar D, Chopade S, Karati D.

Neurodegener Dis Manag. 2026 Apr;16(2):177-190. doi: 10.1080/17582024.2025.2514990. Epub 2025 Jun 26.

Exosome-Mediated Delivery of Amyloid Beta Modulators: A Potential Therapeutic Strategy for Alzheimer's Disease

Mushtaq T, Hameed H, Cláudia Paiva-Santos A, Tariq U, Hameed A.

Mol Neurobiol. 2025 Dec;62(12):15349-15364. doi: 10.1007/s12035-025-05189-6. Epub 2025 Jul 8.

Alzheimer's disease basics: we all should know

Das S.

Neurol Res. 2026 Mar;48(3):330-359. doi: 10.1080/01616412.2025.2529560. Epub 2025 Jul 10.

Crosstalk between copper, Alzheimer's disease, and melatonin

Deepika, Thakur A, Panghal A, Pundir R, Singh C, Goyal M, Namdeo AG, Kumar J.

Biometals. 2025 Oct;38(5):1381-1420. doi: 10.1007/s10534-025-00712-7. Epub 2025 Jul 12.

Multiple Mechanisms and Therapeutic Strategies for the Involvement of AMPK in the Development of Alzheimer's Disease

Yu L, Yang X, Lei HP, Hu YT, Wu LN, Zhou SY, Jin F.

Mol Neurobiol. 2025 Dec;62(12):15390-15409. doi: 10.1007/s12035-025-05162-3. Epub 2025 Jul 15.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias